Transcatheter interventions for valvular heart diseases in liver cirrhosis patients

Area of Science:

• Cardiology
• Hepatology
• Interventional Cardiology

Background:

• Increasing prevalence of patients with co-existing liver cirrhosis (LC) and severe valvular heart disease.
• This dual pathology presents significant challenges, often precluding liver transplantation.
• LC-related complications like malnutrition, hypoalbuminemia, and hyperdynamic circulation increase procedural risks.

Purpose of the Study:

• To review the management strategies for patients with both severe liver cirrhosis and valvular heart disease.
• To evaluate the risks and benefits of different valvular intervention approaches in this patient population.
• To emphasize the importance of a multidisciplinary approach in patient selection.

Main Methods:

• Review of existing literature and data on valvular interventions in patients with liver cirrhosis.
• Analysis of complication rates associated with surgical versus percutaneous approaches.
• Discussion of factors influencing patient outcomes.

Main Results:

• Patients with severe LC undergoing valvular interventions face elevated risks of bleeding, thrombosis, infection, and renal complications.
• Percutaneous strategies appear to be associated with better outcomes compared to surgical interventions, despite limited comparative data.
• A multidisciplinary team approach is crucial for optimal patient management.

Conclusions:

• Transcatheter valvular interventions may be a preferred option over surgical approaches for select patients with severe liver cirrhosis.
• Careful patient selection by a multidisciplinary team is essential to mitigate risks and improve outcomes.
• Further comparative research is needed to solidify evidence-based guidelines.